The Department of Homeland Security (DHS) is seeking to develop methodologies to rapidly characterize the virulence of existing and emerging biothreats to inform risk assessments, disease preparedness and response activities. Traditional pathogen [Read more]
Scientists have developed a fast and easy-to-use point-of-care diagnostic test that could one day help doctors and hospitals head off the rapid spread of the flu. The gold standard of flu diagnostics [Read more]
An international team of scientists, led by Northwestern University Feinberg School of Medicine, has determined the 3-D atomic structure of more than 1,000 proteins that are potential drug and vaccine targets, to [Read more]
The U.S. military’s Joint Product Director for Biological Detection Systems (JPD-BDS) is conducting a market survey to identify sources capable of manufacturing fully automated biological warfare agent identifiers using Raman Spectroscopy. JPD-BDS [Read more]
The first large-scale epidemiological study of Chagas disease in the United States confirms that the ‘silent killer’ is a major public health challenge for the country. A study of almost 5,000 Latin [Read more]
The Naval Medical Research Unit 6 (NAMRU-6) is seeking to purchase laboratory reagents to be used for molecular diagnosis of Influenza virus, adenovirus, Metapneumovirus, Enterovirus, Rhinovirus, Respiratory Syncytial Virus and Zika virus [Read more]
Microbes rule the world. Constituting some of the earliest forms of life, today they represent the vast majority of living things on our planet by number of individuals. In fact these microorganisms [Read more]
The National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) is seeking proposals for nonclinical product development support for promising interventional agents for infectious disease threats. [Read more]
In response to the threat presented by increasing numbers of infections caused by antimicrobial–resistant (AR) and multidrug-resistant (MDR) Gram-negative bacterial pathogens, the NIAID Division of Microbiology and Infectious Diseases (DMID) has established [Read more]
The Defense Threat Reduction Agency (DTRA) has awarded a contract to MeMed, totaling up to $9.2M, which will fund the completion of MeMed’s point of care platform for distinguishing bacterial from viral [Read more]
© 2017 Global Biodefense